Azenta, Inc. (AZTA)
40.13
+0.97
(+2.48%)
USD |
NASDAQ |
Nov 09, 11:47
Azenta Enterprise Value : 1.440B for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.440B |
| November 05, 2026 | 1.362B |
| November 04, 2026 | 1.439B |
| November 03, 2026 | 1.351B |
| November 02, 2026 | 1.282B |
| October 30, 2026 | 1.435B |
| October 29, 2026 | 1.532B |
| October 28, 2026 | 1.504B |
| October 27, 2026 | 1.436B |
| October 26, 2026 | 1.352B |
| October 23, 2026 | 1.323B |
| October 22, 2026 | 1.302B |
| October 21, 2026 | 1.335B |
| October 20, 2026 | 1.289B |
| October 19, 2026 | 1.251B |
| October 16, 2026 | 1.218B |
| October 15, 2026 | 1.324B |
| October 14, 2026 | 1.353B |
| October 13, 2026 | 1.383B |
| October 12, 2026 | 1.379B |
| October 09, 2026 | 1.377B |
| October 08, 2026 | 1.301B |
| October 07, 2026 | 1.296B |
| October 06, 2026 | 1.448B |
| October 05, 2026 | 1.596B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.422B |
| October 01, 2026 | 1.235B |
| September 30, 2026 | 1.253B |
| September 29, 2026 | 1.226B |
| September 28, 2026 | 1.225B |
| September 25, 2026 | 1.215B |
| September 24, 2026 | 1.223B |
| September 23, 2026 | 1.218B |
| September 22, 2026 | 1.226B |
| September 21, 2026 | 1.203B |
| September 18, 2026 | 1.180B |
| September 17, 2026 | 1.198B |
| September 16, 2026 | 1.179B |
| September 15, 2026 | 1.171B |
| September 14, 2026 | 1.128B |
| September 11, 2026 | 1.076B |
| September 10, 2026 | 1.047B |
| September 09, 2026 | 1.045B |
| September 08, 2026 | 1.075B |
| September 04, 2026 | 1.097B |
| September 03, 2026 | 1.090B |
| September 02, 2026 | 1.114B |
| September 01, 2026 | 1.107B |
| August 31, 2026 | 1.155B |
| August 28, 2026 | 1.168B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.47B |
| Bio-Rad Laboratories, Inc. | 9.958B |
| Bruker Corp. | 10.97B |
| Danaher Corp. | 184.07B |
| Harvard Bioscience, Inc. | 75.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.529M |
| Revenue (Quarterly) | 161.18M |
| Total Expenses (Quarterly) | 162.71M |
| EPS Diluted (Quarterly) | 0.0542 |
| Gross Profit Margin (Quarterly) | 44.89% |
| Profit Margin (Quarterly) | -0.95% |
| Earnings Yield | -6.64% |
| Normalized Earnings Yield | -0.6003 |